Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial
Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.

Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublications section now indicates that entries are automatically filled from PubMed and updates the revision label to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding lapse notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedNo significant additions or deletions were detected on the page between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange Detected- Updated to revision v3.2.0 and added a government operating-status notice. - Removed Mature T-cell and NK-cell non-Hodgkin lymphoma from current content.SummaryDifference3%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated to v3.0.2; the Back to Top element was removed.SummaryDifference0.1%

Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.